Tag: nasdaq:cfrx

April 14, 2019

5 Top Weekly NASDAQ Biotech Stocks: PhaseBio Gets Breakthrough Therapy Designation

Vital Therapies, Precipio, Chimerix, ContraFect and PhaseBio Pharmaceuticals were last week's top gainers.
December 2, 2018

5 Top Weekly NASDAQ Biotech Stocks: Arsanis Gains 271 Percent

Arsanis, Tyme Technologies, CohBar, Cocrystal Pharma and Contrafect were last week's top gainers.
July 27, 2018

ContraFect Prices $10 Million Public Offering of Common Stock

ContraFect (NASDAQ:CFRX) has announced the pricing of its underwritten public offering of five million shares of its common stock at...